Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to 0.05%.

  • Eton Pharmaceuticals' Return on Capital Employed rose 3200.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 3200.0%. This contributed to the annual value of 0.08% for FY2024, which is 200.0% up from last year.
  • According to the latest figures from Q3 2025, Eton Pharmaceuticals' Return on Capital Employed is 0.05%, which was up 3200.0% from 0.01% recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Return on Capital Employed ranged from a high of 0.09% in Q3 2023 and a low of 0.57% during Q2 2022
  • Its 5-year average for Return on Capital Employed is 0.25%, with a median of 0.34% in 2023.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first soared by 18400bps in 2021, then plummeted by -4600bps in 2024.
  • Over the past 5 years, Eton Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.07% in 2021, then plummeted by -639bps to 0.49% in 2022, then surged by 84bps to 0.08% in 2023, then rose by 7bps to 0.07% in 2024, then soared by 37bps to 0.05% in 2025.
  • Its Return on Capital Employed stands at 0.05% for Q3 2025, versus 0.01% for Q2 2025 and 0.04% for Q1 2025.